AI In Pharma Market Report 2026

AI In Pharma Market Overview

• AI In Pharma market size has reached to $3.78 billion in 2025 • Expected to grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.4% • Growth Driver: Cloud-Based Drug Discovery Platforms Propel AI Adoption In Pharma For Enhanced Research And Collaboration • Market Trend: Companies Embrace Generative AI In Pharma To Enhance Patient Interactions And Record Management • North America was the largest region in 2025.

What Is Covered Under AI In Pharma Market?

AI in pharma refers to the use of automated algorithms for jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments. The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning and by drug type into small molecule, and large molecules, by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

What Is The AI In Pharma Market Growth Forecast?

The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to precision medicine adoption, AI based clinical trials, demand for cost efficient drug discovery, growth of personalized therapies, integration of genomics data. Major trends in the forecast period include AI driven drug discovery, clinical trial optimization, predictive disease modeling, real time patient data analytics, automated research and development.

Global AI In Pharma Market Segmentation

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning 2) By Drug Type: Small Molecule, Large Molecules 3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction Subsegments: 1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems 2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining 3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies 4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models

What Is The Driver Of The AI In Pharma Market?

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy, and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical, and biological data by providing secure data storage options. For instance, in 2025, according to the Eurostat, a Luxembourg-based statistical office of the European Union, in 2023, 45% of EU businesses purchased cloud computing services. Large enterprises were significantly more inclined to adopt cloud solutions than SMEs, with 78% of large businesses using cloud services compared to 44% of SMEs. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma industry growth during the forecast period.

Key Players In The Global AI In Pharma Market

Major companies operating in the AI in pharma market are Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions

Global AI In Pharma Market Trends and Insights

Major companies operating in the AI in pharma market are focusing on developing technological advancements such as AI-powered medical consultation enhancement tools to improve diagnostic accuracy, streamline clinical workflows, and support timely decision-making for healthcare professionals. AI-powered medical consultation enhancement tools use large language models (LLMs) to generate clinical summaries, automate documentation, and interpret patient-provided information to optimize physician efficiency. For instance, in October 2023, Ubie Inc., a Japan-based medical AI startup, introduced a generative AI–driven feature for doctors that streamlines medical record documentation and summarizes patient findings. The feature, known as the medical interview summary function, uses an LLM to automatically condense 20–30 patient responses related to symptoms and lifestyle habits collected through the Ubie Medical Navi platform. By presenting concise summaries directly on the doctor’s screen, the tool allows physicians to quickly understand patient concerns, reduce administrative burden, and improve the overall quality and speed of medical consultations.

What Are Latest Mergers And Acquisitions In The AI In Pharma Market?

In July 2023, BioNTech SE, a Germany-based biotechnology company that develops and manufactures active immunotherapies, acquired InstaDeep for an undisclosed amount. The acquisition aims to enhance BioNTech’s AI-driven drug discovery and development capabilities, accelerating the creation of next-generation immunotherapies and vaccines. InstaDeep is a UK-based technology company specializing in artificial intelligence (AI) and machine learning (ML) solutions.

Regional Insights

North America was the largest region in the AI in pharma market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Pharma Market?

The AI in the pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimizing material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Pharma Market Report 2026?

The ai in pharma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in pharma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.